Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.01B |
| 2 |
Humana
HUM
|
+$659M |
| 3 |
Apple
AAPL
|
+$579M |
| 4 |
Microsoft
MSFT
|
+$515M |
| 5 |
Home Depot
HD
|
+$508M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$744M |
| 2 |
McDonald's
MCD
|
+$604M |
| 3 |
Cigna
CI
|
+$500M |
| 4 |
Digital Realty Trust
DLR
|
+$424M |
| 5 |
Amazon
AMZN
|
+$407M |
Sector Composition
| 1 | Technology | 19.72% |
| 2 | Healthcare | 16.81% |
| 3 | Consumer Discretionary | 10.08% |
| 4 | Industrials | 8.99% |
| 5 | Financials | 8.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5001
Perion Network
PERI
$443M
| $47.2K | ﹤0.01% |
1,542
-45,704
| -97% | -$1.4M |
|
5002
Reviva Pharmaceuticals
RVPH
$18.1M
| $47K | ﹤0.01% |
9,634
-73,587
| -88% | -$359K |
|
|
MMT
5003
MFS Multimarket Income Trust
MMT
$263M
| $47K | ﹤0.01% |
+11,026
| New | +$47K |
|
5004
Teucrium Soybean Fund
SOYB
$25.3M
| $46.8K | ﹤0.01% |
+1,728
| New | +$46.8K |
|
5005
Apyx Medical
APYX
$86.6M
| $46.3K | ﹤0.01% |
14,456
+11,791
| +442% | +$37.7K |
|
5006
Wearable Devices
WLDS
$12.3M
| $46.2K | ﹤0.01% |
+741
| New | +$46.2K |
|
|
GLO
5007
Clough Global Opportunities Fund
GLO
$245M
| $46.2K | ﹤0.01% |
+10,438
| New | +$46.2K |
|
5008
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
$62.8M
| $46.2K | ﹤0.01% |
388
-2,715
| -87% | -$323K |
|
5009
American Shared Hospital Services
AMS
$16.5M
| $46.1K | ﹤0.01% |
18,681
-14,542
| -44% | -$35.9K |
|
5010
Century Communities
CCS
$1.96B
| $45.9K | ﹤0.01% |
687
-58,275
| -99% | -$3.89M |
|
5011
Urban One Class A
UONE
$67.6M
| $45.8K | ﹤0.01% |
9,125
-30,173
| -77% | -$151K |
|
|
LGHL
5012
Lion Group Holding
LGHL
$5.89M
| $45.7K | ﹤0.01% |
+915
| New | +$45.7K |
|
|
CMCT
5013
Creative Media & Community Trust
CMCT
$5.49M
| $45.4K | ﹤0.01% |
46
-23
| -33% | -$22.7K |
|
|
QSG
5014
QuantaSing Group
QSG
$510M
| $45.3K | ﹤0.01% |
+19,276
| New | +$45.3K |
|
5015
Worksport
WKSP
$22.3M
| $45.2K | ﹤0.01% |
2,153
+1,371
| +175% | +$28.8K |
|
5016
Exelon
EXC
$43.8B
| $44.9K | ﹤0.01% |
1,189
-279,422
| -100% | -$10.6M |
|
|
PBLA
5017
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
| $44.8K | ﹤0.01% |
+1,793
| New | +$44.8K |
|
5018
VistaGen Therapeutics
VTGN
$91.4M
| $44.8K | ﹤0.01% |
8,552
-11,319
| -57% | -$59.3K |
|
5019
OraSure Technologies
OSUR
$247M
| $44.8K | ﹤0.01% |
7,550
-223,455
| -97% | -$1.33M |
|
|
VCSA
5020
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $43.9K | ﹤0.01% |
4,765
+3,195
| +204% | +$29.5K |
|
5021
XBiotech
XBIT
$82.9M
| $43.9K | ﹤0.01% |
10,653
-5,946
| -36% | -$24.5K |
|
|
IH
5022
iHuman
IH
$146M
| $43.8K | ﹤0.01% |
14,510
+4,146
| +40% | +$12.5K |
|
5023
ARS Pharmaceuticals
SPRY
$968M
| $43.6K | ﹤0.01% |
11,538
-208,810
| -95% | -$789K |
|
5024
Dime Community Bancshares
DCOM
$1.36B
| $43.5K | ﹤0.01% |
2,181
-37,508
| -95% | -$749K |
|
5025
BioNexus Gene Lab
BGLC
$9.65M
| $43.5K | ﹤0.01% |
+5,175
| New | +$43.5K |
|